This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Obesity Management Market

Popularity of Obesity Management System is No Longer Lean and Slim. Take the Health Check of the Market with FMI

Obesity Management Market by Drug Type, Surgery Type, Distribution Channel & Region - Forecast 2022 - 2032

Obesity Management Market Outlook (2022-2032)

[324 Pages Report] The obesity management market is expected to grow with a CAGR of 5.1%, from USD 828.71 million in 2022 to USD 1362.80 million by 2032. Due to the steep rise in obesity prevalence over the last two decades, the obesity management market is expected to generate significant revenue in the future.

The major factors expected to drive the obesity management market are an increase in the obese population, an increase in the number of bariatric surgeries, an increase in the adoption of online weight loss and weight management programmes, an increase in disposable income in developing economies, sedentary lifestyle, and increased government initiatives to raise awareness among obese populations.

Attributes

Details

Obesity Management Market CAGR (2022-2032)

5.1%

Obesity Management Market Size (2022)

USD 828.71 million

Obesity Management Market Size (2032)

USD 1362.80 million

Customize this Report

Let us know your requirement to get
100% FREE customization

The Pertinent Windows Of Opportunity For Market Participants In The Coming Decade

Obesity affects one in every three adults in North America. Obesity causes a slew of chronic diseases, many of which can be avoided with proper weight management. Obese patients should be treated for the initial stage of hypertension by losing weight through lifestyle changes, pharmacological treatment, and/or bariatric surgery, according to the AHA.

The NHS in the United Kingdom has suggested that weight loss programmes educate people about the dangers of obesity and assist obese people in losing weight. People are becoming more aware of their physical appearance.

Elements Curtailing Obesity Management Demand

The high cost of surgeries and drugs may be a barrier to obesity management. Weight loss surgery is not reimbursed favourably in developing countries. Because weight management is a time-consuming process, medical payers are hesitant to provide reimbursement.

Furthermore, concerns about the safety of obesity management drugs are cruising clinical trials, with only a few drugs reaching the market. Drug-induced cardiovascular disease or cancer can be caused by certain drug formulations. These incidents have the potential to result in drug recalls.

The FDA, for example, has requested that Eisai withdraw its weight-loss drug Belviq from the market after clinical trials revealed an increased incidence of cancer in users.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

The Key Determinants Are Generating Buzz Of Obesity Management

Geriatric population growth in developed countries, primarily due to improved healthcare leading to increased life expectancy, is driving the obesity management market. This is because geriatric people are highly susceptible to gaining noticeable body fat while losing muscle mass and functioning ability. As a result, the geriatric population is a critical segment of the obesity management market in both the short and long term.

Aside from that, genetics and medication side effects are linked to obesity, which must be handled with the aid of obesity management programmes. This helps to fuel the obesity management market.

Comparative View Of Adjacent Obesity Management Market

Obesity Management Market:

Attributes

Obesity Management Market

CAGR (2022-2032)

5.1%

Market Value (2028)

USD 1116.92 million

Growth Factor

An increasing number of bariatric surgeries are being performed.

Opportunity

Online weight loss and weight management programmes are becoming more popular.

Key Trends

Expanding government initiatives to raise awareness among obese people.

Clinical Alarm Management Market:

Attributes

Clinical Alarm Management Market

CAGR (2022-2032)

10.4%

Market Value (2028)

USD 5.96 Billion

Growth Factor

The rising demand for healthcare, as well as the growing patient population, has resulted in an increase in the frequency of patient alarms, regardless of priority.

Opportunity

With rising disease prevalence and a growing geriatric population, clinical alarms have the potential to reduce costs and facilitate better patient management, which is a key contributor to market growth.

Key Trends

Electronic health records are becoming more popular.

Dietary Fibers Market:

Attributes

Dietary Fibers Market

CAGR (2022-2032)

12.6%

Market Value (2028)

USD 13.84 Billion

Growth Factor

The growing elderly population worldwide, combined with increased consumption of fortified food products, has driven the dietary fibre market.

Opportunity

Growing health consciousness among consumers worldwide, as well as sensitivity to nutrient-rich products, has been major driving factors in the expansion of the supplement industry.

Key Trends

Growing young population across the region, government directives to include fiber-rich foods in daily diets, and rising per-capita income are some of the factors driving Asia Pacific dietary fibres market growth.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Which Is The Leading Segment In The Obesity Management Market By Drug Type?

The liraglutide had the largest market share of 32.4%. Liraglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist with a long pharmacokinetic profile that preserves biological activity.

These products promote weight loss by suppressing appetite and energy consumption. GLP-1 receptor agonists can also cause significant weight loss in a short period of time, which will drive growth in the coming decade.

Which Is The Leading Segment In The Obesity Management Market By Surgery Type?

Gastric sleeve surgery will remain dominant in the market during the forecast period, with an estimated 43.5% market share by the end of 2032. Gastric sleeve surgery is very convenient and safe, with excellent patient outcomes.

This procedure induces hormonal changes to aid in weight loss. These hormones not only help with weight loss, but also with high blood pressure and heart disease caused by obesity. It is the simplest methodology and requires less time in surgery.

Which Is The Leading Segment In The Obesity Management Market By Distribution Channel?

The hospital pharmacies will account for more than 50% of the global distribution channel. Elevated footfall in hospitals for anti-obesity counseling sessions contributes to a large share of market revenue.

Regional Outlook

North America

With a total market share of more than 63.0% in 2021, the United States is expected to maintain a high growth rate throughout the forecast period. Obesity is a major health issue in the country, resulting in a variety of diseases.

North America is expected to generate significant revenue in the obesity management market in the coming years. Factors like a high population awareness, the presence of prominent drug manufacturers, and the rising prevalence of obesity account for the region's rapid growth in the obesity management market.

The bupropion and naltrexone segment leads the North American obesity management market and is likely to sustain its lead, making it highly appealing to stakeholders.

Europe

Europe contributes significantly to the obesity management market's revenue. Obesity in the region is exacerbated by high intake of processed meats and a high prevalence of lifestyle diseases. The availability of obesity management health programmes and government-led obesity management health centres bodes well for the region's obesity management market growth.

Asia Pacific

Asia Pacific is rapidly emerging as a key market for obesity management. Obesity management programmes have emerged as a result of the region's developing countries' excessive rise in obesity incidence as a result of changing lifestyle. This fuels the regional obesity management market.

Propensity for Obesity Management Growth in India

India dominates the South Asian market with a market share of 60.9% and is expected to grow at a CAGR of 4.8%. Rising healthcare expenditures are expected to strengthen the country's market.

Obesity among adults is expected to triple between 2010 and 2040, with an estimated 30% of the population being overweight by that time. Obesity is increasing in the country due to increased consumption of energy-dense foods, sedentary lifestyle, a lack of health care services, and an inadequate financial support.

Germany's Key Growth Enabling Factors

Germany will hold 17.6% of the European obesity management market in 2021. The Robert Koch Institute reports that 67% of adults in Germany are overweight. Germany has a significant problem with high cholesterol and type 1 diabetes.

The German federal government is enacting policies to combat the country's growing obesity problem. In addition, the number of anti-obesity clinics in the country has increased. These factors will contribute to the expansion of obesity management in the country.

The Russian Obesity Management Market is Financially Viable

With a market value of US$ 36.6 Mn in 2021, Russia occupies an important financially rewarding position in Europe. Since 2014, the number of Russians diagnosed with obesity has increased by nearly 50%. According to the WHO, more than 60% of Russians are overweight, with 20% being obese.

The Russian Health Ministry is constantly striving to create strategies for enhancing the population's overall health. According to the World Factbook, the prevalence of adult obesity in Russia is 23.1%.

The Growth Potential in China's Obesity Management Market

The obesity management market in China is growing at a CAGR of 4.3% and is expected to account for more than 42% of the East Asian market over the forecast period. According to national survey data, more than half of all Chinese adults are now overweight or obese.

Rapid economic growth in the country in recent decades has resulted in significant changes in lifestyle, diet, and exercise habits. According to the National Health Commission report from 2020, more than half of adults are classified as overweight, with 16.4% being obese.

How Is The Start-Up Ecosystem In The Obesity Management Market?

Business models evolve over time, sometimes as a result of changes in the obesity management market, and sometimes as a result of technological advancements, resulting in the emergence of new and exciting obesity management market trends.

Standout Market Players You Should Know: Allurion Insights, Apollo Endosurgery, Inc., Obalon Therapeutics, and Glyscend Therapeutics

  • Launch:

Allurion Insights, a new and powerful addition to the Allurion Virtual Care Suite, was launched today by Allurion Technologies, a pioneering leader in the development of innovative, scalable, and trusted weight loss experiences. Allurion Insights is a weight-loss provider-specific integrated remote patient monitoring and telehealth solution.

  • Approval:

Apollo Endosurgery, Inc., a leader in minimally invasive endoscopic surgical products for bariatric and gastrointestinal procedures, announced that the US Food and Drug Administration (FDA) has approved the ORBERATM Intragastric Balloon to help adult patients with obesity (BMI 30 to 40) lose and maintain weight.

  • Approval:

Obalon Therapeutics is making its stock market debut with a $75 million IPO to fund the commercialization of its weight loss balloon device in the United States. The product launch comes just a few weeks after Obalon filed for an IPO and revealed that its ingestible weight loss balloon had received FDA PMA approval.

  • Financing Round

Glyscend Therapeutics has completed a $20.5 million Series A financing round. The round of funding was led by healthcare investors Brandon Capital Partners, through its Medical Research Commercialisation Fund (MRCF), and Santé Ventures, and will be used to support the development of the company's novel oral polymer therapy for patients with T2D and other metabolic diseases. In 2019, Breakout Labs provided seed funding.

How Competition Influences The Obesity Management Market?

The obesity management market is relatively consolidated, with only a few major players competing. Humongous players in the obesity management market are involved in R&D for product innovation and development of existing products.

GlaxoSmithKline Plc, VIVUS, Inc., Novo Nordisk A/S, Currax Pharmaceuticals LLC, Cheplapharm Arzneimittel GmbH, Bausch Health Companies Inc., and Takeda Pharmaceuticals, Inc. are among the prominent companies operating in the obesity management market.

Recent Development

Date January 2018
Company Name H2-Pharma
Strategy Collaboration
Details H2-Pharma announced collaboration with Cheplapharm Arzneimittel GmbH in January 2018 and re-launched XENICAL® 120 mg capsules through its newly formed branded division.
Date February 2020
Company Name VIVUS, Inc.
Strategy Collaboration
Details VIVUS, Inc. announced in February 2020 that its Korean marketing partner, Alvogen, had launched Qsymia in the Republic of Korea.
Date June 2021
Company Name Novo Nordisk
Strategy FDA approval
Details Novo Nordisk received FDA approval for Wegovy semaglutide injection in adults with at least one weight-related condition in June 2021.

Key Players

Key Segments

By Drug Type:

  • Bupropion and Naltrexone
  • Orlistat
  • Lorcaserin
  • Phentermine and Topiramate
  • Liraglutide

By Surgery Type:

  • Gastric Bypass Surgery
  • Adjustable Gastric Banding Surgery
  • Gastric Sleeve Surgery
  • Duodenal Switch Surgery
  • Others

By Distribution Channel:

  • Hospitals Pharmacies
  • Retail Pharmacies
  • E-commerce

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • MEA
  • Europe

Frequently Asked Questions

The Obesity Management Market is predicted to grow at 5.1% CAGR through 2032.

United States Obesity Management Market holds the highest revenue potential.

The Obesity Management Market size is anticipated to be over USD 828.71 million in 2022.

The Obesity Management Market is expected to surpass USD 1362.80 million by 2032.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusion and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Method Innovation / Development Trends

4. Market Background

    4.1. Macro-Economic Factors

        4.1.1. Global GDP Growth Outlook

        4.1.2. Global Healthcare Outlook

        4.1.3. Per Capita Healthcare Expenditure Outlook

    4.2. Forecast Factors - Relevance & Impact

        4.2.1. Increasing Focus On Body Toning and Grooming Therapy

        4.2.2. Rise in Incidence Rate of lifestyle diseases

        4.2.3. Growing Adoption and Demand for Obesity Treatment

        4.2.4. Product Launch

        4.2.5. Increasing Spending On Healthcare Per Capita

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunity Analysis

5. COVID19 Crisis Analysis

    5.1. Current COVID19 Probable Future Impact

    5.2. Current GDP Projection and Probable Impact

    5.3. Current Economic Projection as compared to 2008 financial analysis

    5.4. COVID19 and Impact Analysis

    5.5. 2020 Market Scenario

    5.6. Recovery Scenario - Short term, Midterm and Long Term Impact

6. Key Success Factor

    6.1. Disease Epidemiology

    6.2. Regulatory Scenario

    6.3. Drug Pipeline Assessment

7. Global Obesity Management Market Value (US$ Mn) Analysis 2017–2020 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2017–2020

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Obesity Management Market 2017–2020 and Forecast 2022-2032, By Drug Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) By Drug Type, 2017–2020

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Type, 2022-2032

        8.3.1. Bupropion and Naltrexone

        8.3.2. Orlistat

        8.3.3. Lorcaserin

        8.3.4. Phentermine and Topiramate

        8.3.5. Liraglutide

    8.4. Market Attractiveness Analysis By Drug Type

9. Global Obesity Management Market 2017–2020 and Forecast 2022-2032, By Surgery Type

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) By Surgery Type , 2017–2020

    9.3. Current and Future Market Size (US$ Mn)) Analysis and Forecast By Surgery Type , 2022-2032

        9.3.1. Gastric Bypass Surgery

        9.3.2. Adjustable Gastric Banding Surgery

        9.3.3. Gastric Sleeve Surgery

        9.3.4. Duodenal Switch Surgery

        9.3.5. Others

    9.4. Market Attractiveness Analysis By Surgery Type

10. Global Obesity Management Market 2017–2020 and Forecast 2022-2032, By Distribution Channel

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) By Distribution Channel , 2017–2020

    10.3. Current and Future Market Size (US$ Mn)) Analysis and Forecast By Distribution Channel, 2022-2032

        10.3.1. Hospitals Pharmacies

        10.3.2. Retail Pharmacies

        10.3.3. E-commerce

    10.4. Market Attractiveness Analysis By Distribution Channel

11. Global Obesity Management Market 2017–2020 and Forecast 2022-2032, by Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2017–2020

    11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2032

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. South Asia

        11.3.5. East Asia

        11.3.6. Oceania

        11.3.7. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America Obesity Management Market 2017–2020 and Forecast 2022-2032

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2017–2020

    12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.3.1. By Country

            12.3.1.1. U.S.

            12.3.1.2. Canada

        12.3.2. By Drug Type

        12.3.3. By Surgery Type

        12.3.4. By Distribution Channel

    12.4. Market Attractiveness Analysis

    12.5. Key Market Participants - Intensity Mapping

    12.6. Drivers and Restraints - Impact Analysis

13. Latin America Obesity Management Market 2017–2020 and Forecast 2022-2032

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2017–2020

    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        13.3.1. By Country

            13.3.1.1. Brazil

            13.3.1.2. Mexico

            13.3.1.3. Rest of Latin America

        13.3.2. By Drug Type

        13.3.3. By Surgery Type

        13.3.4. By Distribution Channel

    13.4. Market Attractiveness Analysis

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. Europe Obesity Management Market 2017–2020 and Forecast 2022-2032

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2017–2020

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        14.3.1. By Country

            14.3.1.1. Germany

            14.3.1.2. Italy

            14.3.1.3. France

            14.3.1.4. U.K.

            14.3.1.5. Spain

            14.3.1.6. Russia

            14.3.1.7. BENELUX

            14.3.1.8. Poland

            14.3.1.9. Nordic

            14.3.1.10. Rest of Europe

        14.3.2. By Drug Type

        14.3.3. By Surgery Type

        14.3.4. By Distribution Channel

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. East Asia Obesity Management Market 2017–2020 and Forecast 2022-2032

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2017–2020

    15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        15.3.1. By Country

            15.3.1.1. China

            15.3.1.2. Japan

            15.3.1.3. South Korea

        15.3.2. By Drug Type

        15.3.3. By Surgery Type

        15.3.4. By Distribution Channel

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. South Asia Obesity Management Market 2017–2020 and Forecast 2022-2032

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2017–2020

    16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        16.3.1. By Country

            16.3.1.1. India

            16.3.1.2. Thailand

            16.3.1.3. Indonesia

            16.3.1.4. Malaysia

            16.3.1.5. Rest of South Asia

        16.3.2. By Drug Type

        16.3.3. By Surgery Type

        16.3.4. By Distribution Channel

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. Oceania Obesity Management Market 2017–2020 and Forecast 2022-2032

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2017–2020

    17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        17.3.1. By Country

            17.3.1.1. Australia

            17.3.1.2. New Zealand

        17.3.2. By Drug Type

        17.3.3. By Surgery Type

        17.3.4. By Distribution Channel

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Obesity Management Market 2017–2020 and Forecast 2022-2032

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2017–2020

    18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        18.3.1. By Country

            18.3.1.1. GCC Countries

            18.3.1.2. South Africa

            18.3.1.3. Rest of Middle East and Africa

        18.3.2. By Drug Type

        18.3.3. By Surgery Type

        18.3.4. By Distribution Channel

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. Key Countries Obesity Management Market 2022 & 2032

    19.1. Introduction

        19.1.1. Market Value Proportion Analysis, By Key Countries

        19.1.2. Global Vs. Country Growth Comparison

    19.2. U.S. Obesity Management Market

        19.2.1. By Drug Type

        19.2.2. By Surgery Type

        19.2.3. By Distribution Channel

    19.3. Canada Obesity Management Market

        19.3.1. By Drug Type

        19.3.2. By Surgery Type

        19.3.3. By Distribution Channel

    19.4. Brazil Obesity Management Market

        19.4.1. By Drug Type

        19.4.2. By Surgery Type

        19.4.3. By Distribution Channel

    19.5. Mexico Obesity Management Market

        19.5.1. By Drug Type

        19.5.2. By Surgery Type

        19.5.3. By Distribution Channel

    19.6. U.K. Obesity Management Market

        19.6.1. By Drug Type

        19.6.2. By Surgery Type

        19.6.3. By Distribution Channel

    19.7. Germany Obesity Management Market

        19.7.1. By Drug Type

        19.7.2. By Surgery Type

        19.7.3. By Distribution Channel

    19.8. Italy Obesity Management Market

        19.8.1. By Drug Type

        19.8.2. By Surgery Type

        19.8.3. By Distribution Channel

    19.9. France Obesity Management Market

        19.9.1. By Drug Type

        19.9.2. By Surgery Type

        19.9.3. By Distribution Channel

    19.10. Spain Obesity Management Market

        19.10.1. By Drug Type

        19.10.2. By Surgery Type

        19.10.3. By Distribution Channel

    19.11. Russia Obesity Management Market

        19.11.1. By Drug Type

        19.11.2. By Surgery Type

        19.11.3. By Distribution Channel

    19.12. BENELUX Obesity Management Market

        19.12.1. By Drug Type

        19.12.2. By Surgery Type

        19.12.3. By Distribution Channel

    19.13. Poland Obesity Management Market

        19.13.1. By Drug Type

        19.13.2. By Surgery Type

        19.13.3. By Distribution Channel

    19.14. Nordic Obesity Management Market

        19.14.1. By Drug Type

        19.14.2. By Surgery Type

        19.14.3. By Distribution Channel

    19.15. China Obesity Management Market

        19.15.1. By Drug Type

        19.15.2. By Surgery Type

        19.15.3. By Distribution Channel

    19.16. Japan Obesity Management Market

        19.16.1. By Drug Type

        19.16.2. By Surgery Type

        19.16.3. By Distribution Channel

    19.17. South Korea Obesity Management Market

        19.17.1. By Drug Type

        19.17.2. By Surgery Type

        19.17.3. By Distribution Channel

    19.18. India Obesity Management Market

        19.18.1. By Drug Type

        19.18.2. By Surgery Type

        19.18.3. By Distribution Channel

    19.19. Thailand Obesity Management Market

        19.19.1. By Drug Type

        19.19.2. By Surgery Type

        19.19.3. By Distribution Channel

    19.20. Malaysia Obesity Management Market

        19.20.1. By Drug Type

        19.20.2. By Surgery Type

        19.20.3. By Distribution Channel

    19.21. Indonesia Obesity Management Market

        19.21.1. By Drug Type

        19.21.2. By Surgery Type

        19.21.3. By Distribution Channel

    19.22. Australia Obesity Management Market

        19.22.1. By Drug Type

        19.22.2. By Surgery Type

        19.22.3. By Distribution Channel

    19.23. New Zealand Obesity Management Market

        19.23.1. By Drug Type

        19.23.2. By Surgery Type

        19.23.3. By Distribution Channel

    19.24. GCC Countries Obesity Management Market

        19.24.1. By Drug Type

        19.24.2. By Surgery Type

        19.24.3. By Distribution Channel

    19.25. South Africa Obesity Management Market

        19.25.1. By Drug Type

        19.25.2. By Surgery Type

        19.25.3. By Distribution Channel

20. Market Structure Analysis

    20.1. Market Analysis by Tier of Companies

    20.2. Market Share Analysis of Top Players

21. Competition Analysis

    21.1. Competition Dashboard

    21.2. Competition Benchmarking

    21.3. Competition Deep Dive

        21.3.1. GlaxoSmithKline Plc.

            21.3.1.1. Overview

            21.3.1.2. Product Portfolio

            21.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.1.4. Strategy Overview

                21.3.1.4.1. Marketing Strategy

                21.3.1.4.2. Product Strategy

                21.3.1.4.3. Channel Strategy

        21.3.2. VIVUS, Inc.

            21.3.2.1. Overview

            21.3.2.2. Product Portfolio

            21.3.2.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.2.4. Strategy Overview

                21.3.2.4.1. Marketing Strategy

                21.3.2.4.2. Product Strategy

                21.3.2.4.3. Channel Strategy

        21.3.3. Novo Nordisk A/S

            21.3.3.1. Overview

            21.3.3.2. Product Portfolio

            21.3.3.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.3.4. Strategy Overview

                21.3.3.4.1. Marketing Strategy

                21.3.3.4.2. Product Strategy

                21.3.3.4.3. Channel Strategy

        21.3.4. Currax Pharmaceuticals LLC

            21.3.4.1. Overview

            21.3.4.2. Product Portfolio

            21.3.4.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.4.4. Strategy Overview

                21.3.4.4.1. Marketing Strategy

                21.3.4.4.2. Product Strategy

                21.3.4.4.3. Channel Strategy

        21.3.5. Cheplapharm Arzneimittel GmbH

            21.3.5.1. Overview

            21.3.5.2. Product Portfolio

            21.3.5.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.5.4. Strategy Overview

                21.3.5.4.1. Marketing Strategy

                21.3.5.4.2. Product Strategy

                21.3.5.4.3. Channel Strategy

        21.3.6. Bausch Health Companies Inc.

            21.3.6.1. Overview

            21.3.6.2. Product Portfolio

            21.3.6.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.6.4. Strategy Overview

                21.3.6.4.1. Marketing Strategy

                21.3.6.4.2. Product Strategy

                21.3.6.4.3. Channel Strategy

        21.3.7. Takeda Pharmaceuticals, Inc.

            21.3.7.1. Overview

            21.3.7.2. Product Portfolio

            21.3.7.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.7.4. Strategy Overview

                21.3.7.4.1. Marketing Strategy

                21.3.7.4.2. Product Strategy

                21.3.7.4.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Drug Type

Table 02: Global Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Surgery Type

Table 03: Global Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Distribution Channel

Table 04: Global Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Region

Table 05: North America Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Country

Table 06: North America Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Drug Type

Table 07: North America Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Surgery Type

Table 08: North America Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Distribution Channel

Table 09: Latin America Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Country

Table 10: Latin America Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Drug Type

Table 11: Latin America Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Surgery Type

Table 12: Latin America Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Distribution Channel

Table 13: Europe Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Country

Table 14: Europe Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Drug Type

Table 15: Europe Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Surgery Type

Table 16: Europe Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Distribution Channel

Table 17: South Asia Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Country

Table 18: South Asia Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Drug Type

Table 19: South Asia Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Surgery Type

Table 20: South Asia Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Distribution Channel

Table 21: East Asia Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Country

Table 22: East Asia Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Drug Type

Table 23: East Asia Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Surgery Type

Table 24: East Asia Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Distribution Channel

Table 25: Oceania Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Country

Table 26: Oceania Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Drug Type

Table 27: Oceania Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Surgery Type

Table 28: Oceania Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Distribution Channel

Table 29: Middle East & Africa Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Country

Table 30: Middle East & Africa Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Drug Type

Table 31: Middle East & Africa Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Surgery Type

Table 32: North America Obesity Management Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Distribution Channel

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Obesity Management Market Value Analysis (US$ Mn), 2017-2020

Figure 02: Global Obesity Management Market Value Forecast (US$ Mn), 2022-2032

Figure 03: Global Obesity Management Market Absolute $ Opportunity, 2022 - 2032

Figure 04: Global Obesity Management Market Share Analysis (%), By Drug Type, 2022-2032

Figure 05: Global Obesity Management Market Y-o-Y Analysis (%), By Drug Type, 2022-2032

Figure 06: Global Obesity Management Market Attractiveness Analysis by Drug Type, 2022-2032

Figure 07: Global Obesity Management Market Share Analysis (%), By Surgery Type, 2022-2032

Figure 08: Global Obesity Management Market Y-o-Y Analysis (%), By Surgery Type, 2022-2032

Figure 09: Global Obesity Management Market Attractiveness Analysis By Surgery Type, 2022-2032

Figure 10: Global Obesity Management Market Share Analysis (%), By Distribution Channel, 2022-2032

Figure 11: Global Obesity Management Market Y-o-Y Analysis (%), By Distribution Channel, 2022-2032

Figure 12: Global Obesity Management Market Attractiveness Analysis by Distribution Channel, 2022-2032

Figure 13: Global Obesity Management Market Share Analysis (%), By Region, 2022-2032

Figure 14: Global Obesity Management Market Y-o-Y Analysis (%), By Region, 2022-2032

Figure 15: Global Obesity Management Market Attractiveness Analysis by Region, 2022-2032

Figure 16: North America Obesity Management Market Value Share, By Drug Type (2022 E)

Figure 17: North America Obesity Management Market Value Share, By Surgery Type (2022 E)

Figure 18: North America Obesity Management Market Value Share, By Distribution Channel (2022 E)

Figure 19: North America Obesity Management Market Value Share, By Country (2022 E)

Figure 20: North America Obesity Management Market Value Analysis (US$ Mn), 2017-2020

Figure 21: North America Obesity Management Market Value Forecast (US$ Mn), 2022-2032

Figure 22: North America Obesity Management Market Attractiveness Analysis by Drug Type, 2022-2032

Figure 23: North America Obesity Management Market Attractiveness Analysis By Surgery Type, 2022-2032

Figure 24: North America Obesity Management Market Attractiveness Analysis by Distribution Channel, 2022-2032

Figure 25: North America Obesity Management Market Attractiveness Analysis by Country, 2022-2032

Figure 26: Latin America Obesity Management Market Value Share, By Drug Type (2022 E)

Figure 27: Latin America Obesity Management Market Value Share, By Surgery Type (2022 E)

Figure 28: Latin America Obesity Management Market Value Share, By Distribution Channel (2022 E)

Figure 29: Latin America Obesity Management Market Value Share, By Country (2022 E)

Figure 30: Latin America Obesity Management Market Value Analysis (US$ Mn), 2017-2020

Figure 31: Latin America Obesity Management Market Value Forecast (US$ Mn), 2022-2032

Figure 32: Latin America Obesity Management Market Attractiveness Analysis by Drug Type, 2022-2032

Figure 33: Latin America Obesity Management Market Attractiveness Analysis By Surgery Type, 2022-2032

Figure 34: Latin America Obesity Management Market Attractiveness Analysis by Distribution Channel, 2022-2032

Figure 35: Latin America Obesity Management Market Attractiveness Analysis by Country, 2022-2032

Figure 36: Europe Obesity Management Market Value Share, By Drug Type (2022 E)

Figure 37: Europe Obesity Management Market Value Share, By Surgery Type (2022 E)

Figure 38: Europe Obesity Management Market Value Share, By Country (2022 E)

Figure 39: Europe Obesity Management Market Value Share, By Distribution Channel (2022 E)

Figure 40: Europe Obesity Management Market Value Analysis (US$ Mn), 2017-2020

Figure 41: Europe Obesity Management Market Value Forecast (US$ Mn), 2022-2032

Figure 42: Europe Obesity Management Market Attractiveness Analysis by Drug Type, 2022-2032

Figure 43: Europe Obesity Management Market Attractiveness Analysis By Surgery Type, 2022-2032

Figure 44: Europe Obesity Management Market Attractiveness Analysis by Distribution Channel, 2022-2032

Figure 45: Europe Obesity Management Market Attractiveness Analysis by Country, 2022-2032

Figure 46: South Asia Obesity Management Market Value Share, By Drug Type (2022 E)

Figure 47: South Asia Obesity Management Market Value Share, By Surgery Type (2022 E)

Figure 48: South Asia Obesity Management Market Value Share, By Distribution Channel (2022 E)

Figure 49: South Asia Obesity Management Market Value Share, By Country (2022 E)

Figure 50: South Asia Obesity Management Market Value Analysis (US$ Mn), 2017-2020

Figure 51: South Asia Obesity Management Market Value Forecast (US$ Mn), 2022-2032

Figure 52: South Asia Obesity Management Market Attractiveness Analysis by Drug Type, 2022-2032

Figure 53: South Asia Obesity Management Market Attractiveness Analysis By Surgery Type, 2022-2032

Figure 54: South Asia Obesity Management Market Attractiveness Analysis by Distribution Channel, 2022-2032

Figure 55: South Asia Obesity Management Market Attractiveness Analysis by Country, 2022-2032

Figure 56: East Asia Obesity Management Market Value Share, By Drug Type (2022 E)

Figure 57: East Asia Obesity Management Market Value Share, By Surgery Type (2022 E)

Figure 58: East Asia Obesity Management Market Value Share, By Distribution Channel (2022 E)

Figure 59: East Asia Obesity Management Market Value Share, By Country (2022 E)

Figure 60: East Asia Obesity Management Market Value Analysis (US$ Mn), 2017-2020

Figure 61: East Asia Obesity Management Market Value Forecast (US$ Mn), 2022-2032

Figure 62: East Asia Obesity Management Market Attractiveness Analysis by Drug Type, 2022-2032

Figure 63: East Asia Obesity Management Market Attractiveness Analysis By Surgery Type, 2022-2032

Figure 64: East Asia Obesity Management Market Attractiveness Analysis by Distribution Channel, 2022-2032

Figure 65: East Asia Obesity Management Market Attractiveness Analysis by Country, 2022-2032

Figure 66: Oceania Obesity Management Market Value Share, By Drug Type (2022 E)

Figure 67: Oceania Obesity Management Market Value Share, By Surgery Type (2022 E)

Figure 68: Oceania Obesity Management Market Value Share, By Distribution Channel (2022 E)

Figure 69: Oceania Obesity Management Market Value Share, By Country (2022 E)

Figure 70: Oceania Obesity Management Market Value Analysis (US$ Mn), 2017-2020

Figure 71: Oceania Obesity Management Market Value Forecast (US$ Mn), 2022-2032

Figure 72: Oceania Obesity Management Market Attractiveness Analysis by Drug Type, 2022-2032

Figure 73: Oceania Obesity Management Market Attractiveness Analysis By Surgery Type, 2022-2032

Figure 74: Oceania Obesity Management Market Attractiveness Analysis by Distribution Channel, 2022-2032

Figure 75: Oceania Obesity Management Market Attractiveness Analysis by Country, 2022-2032

Figure 76: Middle East & Africa Obesity Management Market Value Share, By Drug Type (2022 E)

Figure 77: Middle East & Africa Obesity Management Market Value Share, By Surgery Type (2022 E)

Figure 78: Middle East & Africa Obesity Management Market Value Share, By Distribution Channel (2022 E)

Figure 79: Middle East & Africa Obesity Management Market Value Share, By Country (2022 E)

Figure 80: Middle East & Africa Obesity Management Market Value Analysis (US$ Mn), 2017-2020

Figure 81: Middle East & Africa Obesity Management Market Value Forecast (US$ Mn), 2022-2032

Figure 82: Middle East & Africa Obesity Management Market Attractiveness Analysis by Drug Type, 2022-2032

Figure 83: Middle East & Africa Obesity Management Market Attractiveness Analysis By Surgery Type, 2022-2032

Figure 84: Middle East & Africa Obesity Management Market Attractiveness Analysis by Distribution Channel, 2022-2032

Figure 85: Middle East & Africa Obesity Management Market Attractiveness Analysis by Country, 2022-2032

Figure 86: U.S. Obesity Management Market Share Analysis (%), By Drug Type, 2022 & 2032

Figure 87: U.S. Obesity Management Market Share Analysis (%), By Surgery Type, 2022 & 2032

Figure 88: U.S. Obesity Management Market Share Analysis (%), By Distribution Channel, 2022 &2032

Figure 89: Global Vs. U.S. Growth Comparison

Figure 90: Canada Obesity Management Market Share Analysis (%), By Drug Type, 2022 & 2032

Figure 91: Canada Obesity Management Market Share Analysis (%), By Surgery Type, 2022 & 2032

Figure 92: Canada Obesity Management Market Share Analysis (%), By Distribution Channel, 2022 &2032

Figure 93: Global Vs. Canada Growth Comparison

Figure 94: Brazil Obesity Management Market Share Analysis (%), By Drug Type, 2022 & 2032

Figure 95: Brazil Obesity Management Market Share Analysis (%), By Surgery Type, 2022 & 2032

Figure 96: Brazil Obesity Management Market Share Analysis (%), By Distribution Channel, 2022 &2032

Figure 97: Global Vs. Brazil Growth Comparison

Figure 98: Mexico Obesity Management Market Share Analysis (%), By Drug Type, 2022 & 2032

Figure 99: Mexico Obesity Management Market Share Analysis (%), By Surgery Type, 2022 & 2032

Figure 100: Mexico Obesity Management Market Share Analysis (%), By Distribution Channel, 2022 &2032

Figure 101: Global Vs. Mexico Growth Comparison

Figure 102: U.K Obesity Management Market Share Analysis (%), By Drug Type, 2022 & 2032

Figure 103: U.K Obesity Management Market Share Analysis (%), By Surgery Type, 2022 & 2032

Figure 104: U.K. Obesity Management Market Share Analysis (%), By Distribution Channel, 2022 &2032

Figure 105: Global Vs. U.K Growth Comparison

Figure 106: Germany Obesity Management Market Share Analysis (%), By Drug Type, 2022 & 2032

Figure 107: Germany Obesity Management Market Share Analysis (%), By Surgery Type, 2022 & 2032

Figure 108: Germany Obesity Management Market Share Analysis (%), By Distribution Channel, 2022 &2032

Figure 109: Global Vs. Germany Growth Comparison

Figure 110: Italy Obesity Management Market Share Analysis (%), By Drug Type, 2022 & 2032

Figure 111: Italy Obesity Management Market Share Analysis (%), By Surgery Type, 2022 & 2032

Figure 112: Italy Obesity Management Market Share Analysis (%), By Distribution Channel, 2022 &2032

Figure 113: Global Vs. Italy Growth Comparison

Figure 114: France Obesity Management Market Share Analysis (%), By Drug Type, 2022 & 2032

Figure 115: France Obesity Management Market Share Analysis (%), By Surgery Type, 2022 & 2032

Figure 116: France Obesity Management Market Share Analysis (%), By Distribution Channel, 2022 &2032

Figure 117: Global Vs. France Growth Comparison

Figure 118: Spain Obesity Management Market Share Analysis (%), By Drug Type, 2022 & 2032

Figure 119: Spain Obesity Management Market Share Analysis (%), By Surgery Type, 2022 & 2032

Figure 120: Spain Obesity Management Market Share Analysis (%), By Distribution Channel, 2022 &2032

Figure 121: Global Vs. Spain Growth Comparison

Figure 122: Russia Obesity Management Market Share Analysis (%), By Drug Type, 2022 & 2032

Figure 123: Russia Obesity Management Market Share Analysis (%), By Surgery Type, 2022 & 2032

Figure 124: Russia Obesity Management Market Share Analysis (%), By Distribution Channel, 2022 &2032

Figure 125: Global Vs. Russia Growth Comparison

Figure 126: BENELUX Obesity Management Market Share Analysis (%), By Drug Type, 2022 & 2032

Figure 127: BENELUX Obesity Management Market Share Analysis (%), By Surgery Type, 2022 & 2032

Figure 128: BENELUX Obesity Management Market Share Analysis (%), By Distribution Channel, 2022 &2032

Figure 129: Global Vs. BENELUX Growth Comparison

Figure 130: Poland Obesity Management Market Share Analysis (%), By Drug Type, 2022 & 2032

Figure 131: Poland Obesity Management Market Share Analysis (%), By Surgery Type, 2022 & 2032

Figure 132: Poland Australia Obesity Management Market Share Analysis (%), By Distribution Channel, 2022 &2032

Figure 133: Global Vs. Poland Growth Comparison

Figure 134: Nordic Obesity Management Market Share Analysis (%), By Drug Type, 2022 & 2032

Figure 135: Nordic Obesity Management Market Share Analysis (%), By Surgery Type, 2022 & 2032

Figure 136: Nordic Obesity Management Market Share Analysis (%), By Distribution Channel, 2022 &2032

Figure 137: Global Vs. Nordic Growth Comparison

Figure 138: China Obesity Management Market Share Analysis (%), By Drug Type, 2022 & 2032

Figure 139: China Obesity Management Market Share Analysis (%), By Surgery Type, 2022 & 2032

Figure 140: China Obesity Management Market Share Analysis (%), By Distribution Channel, 2022 &2032

Figure 141: Global Vs. China Growth Comparison

Figure 142: Japan Obesity Management Market Share Analysis (%), By Drug Type, 2022 & 2032

Figure 143: Japan Obesity Management Market Share Analysis (%), By Surgery Type, 2022 & 2032

Figure 144: Japan Obesity Management Market Share Analysis (%), By Distribution Channel, 2022 &2032

Figure 145: Global Vs. Japan Growth Comparison

Figure 146: South Korea Obesity Management Market Share Analysis (%), By Drug Type, 2022 & 2032

Figure 147: South Korea Obesity Management Market Share Analysis (%), By Surgery Type, 2022 & 2032

Figure 148: South Korea Obesity Management Market Share Analysis (%), By Distribution Channel, 2022 &2032

Figure 149: Global Vs. South Korea Growth Comparison

Figure 150: India Obesity Management Market Share Analysis (%), By Drug Type, 2022 & 2032

Figure 151: India Obesity Management Market Share Analysis (%), By Surgery Type, 2022 & 2032

Figure 152: India Obesity Management Market Share Analysis (%), By Distribution Channel, 2022 &2032

Figure 153: Global Vs. India Growth Comparison

Figure 154: Thailand Obesity Management Market Share Analysis (%), By Drug Type, 2022 & 2032

Figure 155: Thailand Obesity Management Market Share Analysis (%), By Surgery Type, 2022 & 2032

Figure 156: Thailand Obesity Management Market Share Analysis (%), By Distribution Channel, 2022 &2032

Figure 157: Global Vs. Thailand Growth Comparison

Figure 158: Malaysia Obesity Management Market Share Analysis (%), By Drug Type, 2022 & 2032

Figure 159: Malaysia Obesity Management Market Share Analysis (%), By Surgery Type, 2022 & 2032

Figure 160: Malaysia Obesity Management Market Share Analysis (%), By Distribution Channel, 2022 &2032

Figure 161: Global Vs. Malaysia Growth Comparison

Figure 162: Indonesia Obesity Management Market Share Analysis (%), By Drug Type, 2022 & 2032

Figure 163: Indonesia Obesity Management Market Share Analysis (%), By Surgery Type, 2022 & 2032

Figure 164: Indonesia Obesity Management Market Share Analysis (%), By Distribution Channel, 2022 &2032

Figure 165: Global Vs. Indonesia Growth Comparison

Figure 166: Australia Obesity Management Market Share Analysis (%), By Drug Type, 2022 & 2032

Figure 167: Australia Obesity Management Market Share Analysis (%), By Surgery Type, 2022 & 2032

Figure 168: Australia Obesity Management Market Share Analysis (%), By Distribution Channel, 2022 &2032

Figure 169: Global Vs. Australia Growth Comparison

Figure 170: New Zealand Obesity Management Market Share Analysis (%), By Drug Type, 2022 & 2032

Figure 171: New Zealand Obesity Management Market Share Analysis (%), By Surgery Type, 2022 & 2032

Figure 172: New Zealand Obesity Management Market Share Analysis (%), By Distribution Channel, 2022 &2032

Figure 173: Global Vs. New Zealand Growth Comparison

Figure 174: GCC Countries Obesity Management Market Share Analysis (%), By Drug Type, 2022 & 2032

Figure 175: GCC Countries Obesity Management Market Share Analysis (%), By Surgery Type, 2022 & 2032

Figure 176: GCC Countries Obesity Management Market Share Analysis (%), By Distribution Channel, 2022 &2032

Figure 177: Global Vs. GCC Countries Growth Comparison

Figure 178: South Africa Obesity Management Market Share Analysis (%), By Drug Type, 2022 & 2032

Figure 179: South Africa Obesity Management Market Share Analysis (%), By Surgery Type, 2022 & 2032

Figure 180: South Africa Obesity Management Market Share Analysis (%), By Distribution Channel, 2022 &2032

Figure 181: Global Vs. South Africa Growth Comparison

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Weight Management Market

Published : June 2022

Consumer Product

Weight Training Market

Published : June 2020

Healthcare

Weight Loss and Obesity Management Market

Published : February 2019

Google translate

Obesity Management Market